Medical Article

Sanofi is building on its immunology ambitions by acquiring an early clinical Dren Bio drug candidate that offers a potential first-in-class approach to autoimmune disorders such as lupus. It’s the latest acquisition in what has become an active space for dealmaking. The post Sanofi Expands Immunology Prospects, Acquiring Novel Bispecific Drug in $600M Deal appeared…

A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal.   The post The Hidden Autoimmune Disorder Affecting Our Kids: Understanding PANS and PANDAS appeared first…